Cadmium is a toxic heavy metal and distributed widely in the environment. In addition to damaging the liver, kidneys, and bone, cadmium causes anemia through hemolysis, iron deficiency, and insufficient erythropoietin (EPO) production (renal anemia) along with changes in iron metabolism. Here, we investigated the role of iron in the interdependent progress of three types of anemia in cadmium-injected rats fed iron-sufficient or irondeficient diets for 1 or 3 months. Cadmium injections for 1 month induced renal anemia without renal injury. Injections for 3 months induced hemolysis, iron deficiency, and renal anemia, accompanied by hepatic and renal damage. Iron concentrations in the liver, kidney, and spleen were increased, derived from internally released iron from hemolyzed red blood cells, increased duodenal iron absorption, insufficient erythropoiesis, and hepatic ferritin overproduced by cadmium-induced interleukin-6. Therefore, the iron deficiency anemia was actually apparent. Cadmium suppressed renal EPO production through a direct effect, accumulated iron, and destruction of EPO-producing cells. Increased duodenal iron absorption could be attributed to hypertrophy of the duodenal mucosa derived from anemia. Thus, insufficient EPO production and iron accumulation are the central factors driving anemia in cadmium toxicity.
Cadmium (Cd) is a toxic heavy metal in the environment. Whereas acute Cd exposure induces hepatic injury, chronic intoxication initially results in multiple proximal renal tubular dysfunction, characterized by excess urinary excretion of water, low-molecular weight proteins, calcium, and phosphate, etc. The most severe example is ''itai-itai'' disease, endemic among female Japanese farmers heavily exposed to Cd through polluted agriproducts and river water (Nordberg et al., 2007) .
Cd also induces anemia with three mechanisms. They are as follows: hemolysis due to a deformity of peripheral red blood cells (RBCs) (Kunimoto et al., 1985) , iron deficiency through competing with duodenal iron absorption (Hamilton and Valberg, 1974) , and renal anemia derived from hypoproduction of erythropoietin (EPO) (Horiguchi et al., 1994 (Horiguchi et al., , 2010 , an erythroid-specific glycoprotein hormone produced from the kidneys that regulates the volume of RBCs (Ebert and Bunn, 1999) . We postulate that the three types of anemia develop interdependently with iron, a common factor. For example, iron deficiency stimulates EPO expression through stabilization of hypoxia-inducible factor-a (HIF-a), whereas excess iron leads to EPO suppression (Wang and Semenza, 1993) . Interestingly, Cd induces not only iron deficiency but also iron accumulation in the body, depending on the period or exposure route. Patients with itai-itai disease showed renal anemia, not iron deficiency (Horiguchi et al., 1994; Nogawa et al., 1984) . In animals, increased iron concentration in organs was observed after long-term dietary Cd exposure (Stonard and Webb, 1976) or both acute and chronic parenteral Cd exposure (Maitani and Suzuki, 1986; Sugawara et al., 1984) . These results suggest that Cd interferes with intestinal iron absorption to induce iron deficiency via oral exposure, but Cd highly accumulated in organs after parenteral or long-term oral exposure would induce excess iron accumulation, which could lead to EPO suppression.
One source of the increase in body iron may be the enhanced intestinal iron absorption. At duodenal enterocytes, iron is reduced at the apical membranes by duodenal cytochrome b (Dcytb) (McKie et al., 2001) , internalized through divalent metal transporter 1 (DMT1) (Gunshin et al., 1997) , oxidized at the basolateral membranes by hephaestin (Vulpe et al., 1999) , and exported through ferroportin1 into the bloodstream (Donovan et al., 2000) . In plasma, iron binds to transferrin, transported to the whole body, and endocytosed through transferrin receptor 1 on cell surfaces (Aisen, 2004) . Cd competes with iron transport by DMT1 in CHO cells (Picard et al., 2000) or suppresses itself in Caco-2 cells (Tallkvist et al., 2001) , but its effects on the other factors are unknown. Another source must be the internal iron release by hemolysis. Recycling of iron from senescent RBCs for erythropoiesis is predominantly achieved through phagocytosis by macrophages in the spleen, liver, and bone marrow (Beaumont and Delaby, 2009 ). In macrophages, hemoglobin (Hb) is degraded and the iron released is exported into plasma through ferroportin1 on the membrane. During the process, Cd increases ferroportin1 expression in mouse macrophages (Park and Chung, 2009 ).
Hepcidin, a hepatic peptide hormone (Pigeon et al., 2001 ), binds and downregulates ferroportin1 expressed in enterocytes and macrophages: in iron deficiency, the production is decreased, resulting in increases of duodenal iron absorption and macrophage iron release through ferroportin1 accumulation (Nemeth et al., 2004b) . The hepcidin induction is regulated by a hepatic protein, hereditary hemochromatosis protein (HFE) (Feder et al., 1996) . Intriguingly, interleukin (IL)-6, an inflammatory cytokine, induces hepcidin production (Nemeth et al., 2004a) and Cd induces IL-6 production (Kayama et al., 1995) . Therefore, Cd might affect hepcidin-regulated iron homeostasis through IL-6 production.
Excess iron is stored mainly in the liver in association with ferritin, a hollow protein shell consisting of light and heavy subunits, or the degraded product hemosiderin (Harrison and Arosio, 1996) . Because not only excess iron but also inflammation and the relevant cytokines including IL-1 or IL-6 induce ferritin synthesis (Rogers, 1996) , Cd may cause iron accumulation through ferritin synthesis.
To elucidate the iron role in the development of Cd-induced anemia, we injected Cd to rats fed iron-sufficient or irondeficient diets for 1 or 3 months and investigated hematological indicators, histopathologic changes, iron kinetics using 59 Fe as well as static distribution, and messenger RNA (mRNA) expression of proteins related to iron metabolism. Long-term oral Cd administration mimics human cases such as itai-itai disease, but it would make it difficult to differentiate the dichotomic effect on iron, the accumulation in the organs, and the inhibition of intestinal absorption. Therefore, we injected Cd to observe the direct effect of Cd on iron metabolism in the body. Based on these results, we discuss comprehensively the structure of Cd-induced anemia.
MATERIALS AND METHODS
Animals. Female Wistar rats, aged 5 weeks, were injected with Cd (2 mg/kg, as CdCl 2 ) or the equivalent volume of saline sc twice a week for 1 or 3 months, and fed a low-iron purified diet or basal diet 5755 (TestDiet, Richmond, IN) (the iron contents are 10-20 and 60 ppm, respectively). We selected this experimental design to observe differences in Cd-induced anemia between animals with and without iron deficiency, or between those with and without renal injury. At the indicated months, we collected 24-h urine samples on cold compresses using metabolic cages, then euthanized the rats by taking heparinized peripheral blood from the hearts under diethyl ether anesthesia. Just after that, we took the livers, kidneys, spleens, and intestines, the last of which were further slit longitudinally to wash the contents off with PBS, and the proximal 10% of total length was taken as the duodenum (Horiguchi et al., 2005) . These experiments were carried out under the control of the Animal Research Committee in accordance with the Guidelines on Animal Experiments of Jichi Medical University and the Animal Protection and Management Law (No. 105).
Analyses of peripheral blood and urine. RBC count, Hb, hematocrit (Hct), mean corpuscular volume (MCV), mean corpuscular Hb (MCH), and mean corpuscular Hb concentration in EDTA-added whole-blood samples were measured using a fully automatic blood cell counter, PCE-210 (ERMA, Tokyo, Japan). Reticulocyte counts were determined on smear specimens of whole blood on glass slides stained with reticulocyte capillaries (Cosmo Bio, Tokyo, Japan) using a microscope with a Miller ocular insert. Smear specimens of whole blood on glass slides were stained with May-Giemsa solution for the observation of RBC morphology. The levels of iron, total iron-binding capacity (TIBC), ferritin, and EPO in plasma samples were measured by a colorimetric method, a competitive protein-binding assay, an enzyme immunoassay, and a radioimmunoassay, respectively. The levels of N-acetyl-b-D-glucosaminidase (NAG), glucose, transferrin, and Hb in the urine samples were measured by a synthetic substrate method, an amperometric detection method, ELISA (Panatest Rat Transferrin; Mitsubishi Chemical Medience Corporation, Kumamoto, Japan), and another ELISA (Panatest Rat Hemoglobin; Mitsubishi Chemical Medience Corporation), respectively.
Pathological examinations. The samples of liver and kidney that were immediately washed by manual infusion of freshly prepared 4% paraformaldehyde and subsequent agitation overnight at 4°C, as well as the fresh samples of the spleen and the duodenum, were fixed in 10% formalin and then embedded in paraffin. The paraffin blocks were then sliced, placed onto glass slides, and stained with hematoxylin-eosin after deparaffinization. Immunohistochemistry (IHC) staining for ferritin was performed with hepatic tissue specimens and for ferroportin1 with duodenal and splenic tissue specimens, by using an automated staining workstation, Ventana Discovery XT (Ventana Medical Systems, Inc., Tucson, AZ). In brief, after the deparaffinized sections on glass slides were heated at 95°C and then endogenous biotin was blocked, they were immunoreacted with antibodies against ferritin (Rockland Inc., Gilbertsville, PA) or ferroportin1 (.Alpha Diagnostic International Inc., San Antonio, TX), and biotin-labeled antibodies. Finally, the immunoreactive signals were detected with peroxidase-conjugated streptavidin and its substrate, 3, 3#-diaminobenzidine tetrahydrochloride. These specimens were observed and photographed with a BZ-9000 all-in-one fluorescence microscope (Keyence, Osaka, Japan).
Measurement of metal concentrations in organs and urine. After the peripheral blood remaining in the liver and kidney was manually washed out via the hili using PBS, the tissue homogenates of the liver, kidney, and spleen were then prepared with PBS using a Potter-type homogenizer and digested with an acid mixture (HNO 3 , HClO 4 , and H 2 SO 4 ) on a hot plate at 130-200°C. The urine samples were digested in the same way. After resuspension of the residues in Milli-Q water, the iron and Cd concentrations were analyzed by flameless atomic absorption spectrometry, using a Z-9000 Polarized Zeeman Atomic Absorption Spectrophotometer (Hitachi, Tokyo, Japan).
Kinetic analysis of iron absorption from the intestine. Following overnight fasting, rats were administered~18 kBq 59 Fe (FeCl 3 in 0.5 N hydrochloric acid; Amersham Biosciences, Buckinghamshire, UK) with 1 ml of 100 g/ml iron nitrate by gavage using an esophageal cannula. After 6 h, the rats were killed in the way mentioned above. The radioactivity of each organ and 1 ml of blood as well as the whole 59 Fe solution before administration were counted using an Auto Well Gamma System ARC-2000 (Aloka, Tokyo, Japan), and the relative 59 Fe uptake in the organs was calculated. The relative count remaining in the cannula after administration was less than 0.1%.
Real-time PCR. Five-hundred nanograms of total RNA, purified from 100 mg tissue samples of the liver, kidney, and duodenal mucosa using TRIzol reagent (Invitrogen, Carlsbad, CA), was reverse transcribed into complementary DNA by a PrimeScript RT reagent Kit (TaKaRa, Tokyo, Japan). Then realtime PCR was carried out for the RT products with SYBR Premix Ex Taq (TaKaRa) and each primer pair specific for genes (Supplementary table 1) using the TP800 Thermal Cycler Dice Real Time System (TaKaRa). After the CADMIUM-INDUCED ANEMIA reaction, the primary amounts of DNA templates of the target and reference (glyceraldehyde 3-phosphate dehydrogenase, GAPDH) genes were calculated from the standard curve with the values of CT (threshold cycle), then the relative gene expression was obtained by dividing that of the target gene by the reference.
Statistics. The significance of differences between groups was examined by the Bonferroni-Holm step down test or Student t-test. In some cases, outliers, determined by the Smirnov-Grubbs test, were excluded from analyses. We checked the significance of correlations between parameters by Pearson's or Spearman's rank correlation coefficient and simple or multiple regression analyses.
RESULTS
First, we looked into hematological changes in rats ( Table 1) . The saline-injected rats fed a low-iron diet for 1 and 3 months showed decreases in Hb, Hct, MCV, and MCH and an increase in RBC count, i.e., hypochromic and microcytic anemia, along with a decrease in plasma iron and increases in the reticulocyte count, TIBC, and plasma EPO. These are characteristics of iron deficiency anemia. In contrast, the injection of Cd for 1 month induced normochromic and normocytic anemia, judged by the trends of decrease in the RBC count, Hb, and Hct with almost no changes in MCV and MCH. The plasma EPO level (31.3 mIU/ml) in the Cd-injected rats was significantly lower than that of the rats with iron deficiency anemia (50.3 mIU/ml) (p ¼ 0.013) despite the similar levels of Hb. These results indicate that the anemia was due to insufficient EPO production, i.e., renal anemia. When the rats fed the low-iron diet were injected with Cd, however, the anemia became hypochromic and microcytic along with significant increases in the reticulocyte count and EPO, i.e., iron deficiency anemia.
After the injection of Cd for 3 months, the anemia became much more severe in both diet groups, being hypochromic and microcytic along with low plasma iron and increased TIBC. In addition, the EPO level was not sufficiently elevated, given the very low Hb. Furthermore, there were many deformed broken RBCs in the rats injected with Cd for 3 months (Fig 1) . These results indicate that iron deficiency, renal anemia, and hemolysis were all involved in the development of anemia. It is notable that TIBC, i.e., transferrin, and ferritin in the Cdinjected rats were extraordinarily elevated. The reticulocyte counts always corresponded with EPO levels, suggesting intact erythropoiesis in bone marrow.
Next, we observed the changes to organs. Although there was no abnormal change at 1 month (not shown), the kidneys of the rats injected with Cd for 3 months showed distinct atrophy and degeneration of proximal renal tubular cells accompanied by the infiltration of inflammatory cells and fibrosis along with weight increases ( Figs. 2A and B ; Supplementary table 2), the degree of which was almost the same in both diet groups (not shown). These morphological findings were quite well reconciled with the results of urinary analyses. Urinary levels of volume, glucose, and NAG, all indicators of tubular dysfunction, increased only slightly in the rats injected with Cd for 1 month, but were markedly elevated at 3 months, without any difference between the diets (Table 2) .
Cd injections for 1 month did not cause any abnormality in the livers (not shown), but limited and focal necrosis of hepatic cells along with weight increases was detected at 3 months (Figs. 2C and D; Supplementary table 2). Cd increased the weight of the spleen, almost three times as much as in salineinjected rats at 3 months (Supplementary table 2) . The histology of the splenomegaly showed an accumulation of RBCs (Supplementary fig. 1 ), supporting the hemolysis. In rats fed the low-iron diet for 3 months, hemosiderin disappeared in the spleen of saline-injected rats but occurred in those injected with Cd. The weight of the duodenum was increased by both the low-iron diet and Cd injection, especially at 3 months (Supplementary table 2) , which would be due to hypertrophy of the duodenal mucosa (Supplementary fig. 2 ). The duodenal hypertrophy, however, was actually induced by anemia, not iron deficiency, as evidenced by a multiple regression analysis that showed the most significant negative correlation between the Hb level and duodenal weight in the rats (Supplementary  table S3) .
Then, we confirmed the distribution of Cd in the organs and urine of the rats (Table 3 ). The Cd levels in the liver and kidney were already very high at 1 month of Cd injection and then slightly increased at 3 months, suggesting that a plateau was reached quickly. On the contrary, Cd levels in the spleen at 1 month were much lower than those in the liver and kidney, followed by steep increases at 3 months , meaning a relatively slow accumulation. The urinary Cd excretions showed drastic increases from 1 to 3 months. There was no difference in the distribution of Cd between the diets, suggesting that iron deficiency did not affect the distribution.
Next, we investigated the effect of Cd on iron metabolism in the rats. Iron concentrations in organs and urine of salineinjected rats on the low-iron diet were much lower than the basal diet, indicating that low-iron diet induced distinct iron deficiency (Table 3) . Although the hepatic and splenic iron levels of Cd-injected rats fed the low-iron diet showed slight increases at 1 month, the Cd injections for 3 months induced significant increases in the iron levels of almost all organs in both diets. Notably, the hepatic and splenic iron levels in Cdinjected rats fed the low-iron diet were as much as five times higher than those of saline-injected rats. Although there was no difference in urinary iron levels between the saline-and Cdinjected rats at 1 month, they were significantly higher in the Cd-injected rats at 3 months in both diets. The increased urinary iron excretion would be originated from extraordinarily increased urinary transferrin and Hb excretion, both of which are reabsorbed by renal tubules after being filtered through glomeruli ( Table 2) .
The highly elevated levels of plasma ferritin and hepatic iron in the Cd-injected rats suggested enhanced hepatic ferritin production. Because synthesis of ferritin is regulated at both the transcriptional and the translational levels (Harrison and 200 HORIGUCHI, OGUMA, AND KAYAMA Arosio, 1996), we observed ferritin expression in hepatic tissues by IHC (Fig. 3 ). There were hepatic cells that produced ferritin diffusely around central veins in the saline-injected rats fed the basal diet, which were less on the low-iron diet. In the Cd-injected rats, however, ferritin production was strongly detected in the focally injured hepatic cells, without a significant difference between the diets.
Short-term iron kinetics including intestinal iron absorption and the transfer to organs was further investigated in another set of rats with the same treatment, which were gavaged with 59 Fe (Table 4 ). Overall increases in peripheral blood 59 Fe fractions and decreases in duodenal fractions were observed in the rats fed the low-iron diet, indicating a strong driving force of iron deficiency to pass iron quickly through the duodenum into the blood. A similar trend was seen in the saline-injected rats fed the basal diet at 1 month compared with 3 months, suggesting increased iron absorption due to the excess iron demands for growth around adolescence (Leong et al., 2003) .
On the other hand, 59 Fe fractions in both peripheral blood and duodenum of Cd-injected rats fed both diets were higher, although not significantly, at 3 months than those in the salineinjected rats. To explain the difference of the effects on duodenal iron absorption between iron deficiency and Cd, we performed a multiple regression analysis, demonstrating that the low-iron diet, i.e., iron deficiency, was the strongest contributor to peripheral blood 59 Fe, followed by duodenal Basal diet 12.0 ± 0.4 10.9 ± 0.6 12.5 ± 0.9 7.8 ± 1.0 † ‡ Low-iron diet 10.4 ± 0.5* 9.7 ± 0.7 11.7 ± 1.6 ‡ 6.8 ± 0.7 † ‡ Hct (%) Basal diet 35.2 ± 0.8 30.8 ± 1.2 † 34.7 ± 1.2 19.6 ± 0.9 † ‡ Low-iron diet 29.8 ± 2.0* 27.4 ± 2.3* † 29.7 ± 1.9* 17.6 ± 1.4 † ‡ MCV (lm 3 ) Basal diet 54.9 ± 0.5 52.0 ± 1.0 † 54.8 ± 0.7 34.3 ± 0.8 † ‡ Low-iron diet 44.1 ± 2.6* 42.8 ± 2.8* 31.6 ± 1.9* ‡ 23.8 ± 3.4* † ‡ MCH (pg) Basal diet 18.7 ± 0.8 18.3 ± 0.7 19.8 ± 1.6 13.7 ± 1.5 † ‡ Low-iron diet 15.4 ± 0.7* 15.2 ± 0.8* 12.5 ± 1.8* ‡ 9.2 ± 1. 59 Fe turned into a positive partial correlation coefficient, indicating that there is intrinsically a positive correlation between them, and iron deficiency works as a strong confounding factor for it to inverse the relation. Thus, Cd would increase de novo duodenal iron take-up, followed by a proportional transfer to peripheral blood, whereas iron deficiency enhances passage through the duodenum into blood, resulting in a small amount of iron remaining in duodenum. Fe fraction of the liver in the saline-injected rats fed the basal diet at 1 month was significantly higher than 3 months and decreased by the Cd injections for 3 months, suggesting Cd would hinder the growth-enhanced iron transfer to the liver. The 59 Fe fractions of most of the organs of the rats fed the lowiron diet at both months were higher than those fed the basal diet, indicating that iron transfer to organs was enhanced by iron deficiency. On the other hand, there were no increases in the hepatic and renal 59 Fe fractions of Cd-injected rats, whereas the spleen showed an increase in it parallel to weight, although not significant.
Finally, we investigated mRNA levels of iron metabolismrelated proteins in organs of the rats (Table 5) . Hepatic hepcidin mRNA levels were too low to be detected, and duodenal ferroportin1 levels were increased more than twofold in saline-injected rats fed the low-iron diet compared with those fed the basal diet, suggesting the accumulation of ferroportin1 in the duodenum. Actually, IHC showed that in contrast to the nonlocalized expression of ferroportin1 protein in the duodenal epithelial cells of the rats fed the basal diet, strong staining was detected at the lateral and basal membranes of the cells of the rats fed the low-iron diet at 3 months (Fig. 4) . Duodenal mRNA levels of DMT1 and Dcytb in the saline-injected rats fed the low-iron diet were always around 10 times higher than those in rats fed the basal diet.
The hepatic hepcidin mRNA expression was significantly suppressed by Cd at 1 month, but not at 3 months, in the rats on the basal diet. In addition, the hepcidin mRNA expression increased to a detectable level, although still very low, after the Cd injections for 3 months in the rats fed the low-iron diet. To explain the change in the effect of Cd on hepcidin during the time course, we checked hepatic levels of IL-6 mRNA, a potent inducer of hepcidin. The level of hepatic IL-6 mRNA in Cd-injected rats was nearly 10 times higher than that in saline-injected rats fed each diet at 3 months. Hfe, another factor related to hepcidin expression, was also significantly increased at 3 months of Cd injection.
Duodenal mRNA levels of ferroportin1 did not differ significantly between the saline-and Cd-injected rats. In addition, IHC in the duodenum of rats at 3 months showed that there was no significant difference in ferroportin1 protein expression between saline-and Cd-injected rats fed both the diets (Fig. 4) . Duodenal DMT1, hephaestin, and Dcytb mRNA levels were not significantly changed by Cd either.
We observed ferroportin1 protein expression in macrophages of the spleen, which is regulated by hepcidin, too (Supplementary fig. 3 ). In the saline-injected rats at 3 months, ferroportin1 expression was detected at the cell membranes of splenic macrophages, which was stronger on the low-iron diet than the basal diet. On the other hand, Cd-injected rats showed weaker ferroportin1 expression than the saline-injected ones in both diets.
The hepatic transferrin, transferrin receptor 1, and ferritin mRNA levels were not significantly changed by Cd. The mRNA expression of renal DMT1, which is produced mainly by renal tubular cells (Ferguson et al., 2001) , was decreased in the Cd-injected rats, especially at 3 months, corresponding with the renal tubular dysfunction. Renal IL-6 mRNA levels were highly increased in the Cd-injected rats at 3 months, consistent with the renal injury.
DISCUSSION
Here we demonstrated that injecting rats with Cd for 1 month induced anemia derived from insufficient EPO production, renal anemia, whereas the anemia at 3 months was iron deficiency, hemolytic, and renal. When Cd-injected rats were fed a low-iron diet, iron-deficiency anemia, not renal, was evident at 1 month, whereas at 3 months, the three types of anemia were unchanged. Cd-induced iron deficiency anemia, however, is different from that induced by insufficient dietary iron. The actual amounts of iron in organs of the Cd-injected rats were increased. Transferrin (TIBC), whose production is usually enhanced by low hepatic iron concentration, was increased in the Cd-injected rats despite the relatively high hepatic iron level (Supplementary fig. 4 ). Plasma ferritin level, generally in proportion to the hepatic iron concentration (Olthof et al., 2007) , was elevated, even excessively, in the Cd-injected rats (Supplementary fig. 5 ). Actually, it was previously reported that the ratio of iron/ferritin in the liver of rats with chronic Cd exposure was decreased (Stonard and Webb, Number Basal diet 8 (7) 9 (8) 8 9 Low-iron diet 8 9 9 9 Urine volume (ml)
Basal diet 6.6 ± 1.7 a 5.1 ± 1.2 12.2 ± 3.9 20.9 ± 10.4 † ‡ Low-iron diet 6.5 ± 1.9 8.8 ± 6.6 a 7.8 ± 4.6 22.4 ± 5.6 † ‡ Glucose (mg) Basal diet 2.4 ± 0.4 3.3 ± 1.1 2.8 ± 1.0 10.2 ± 7.7 † ‡ Low-iron diet 2.8 ± 1.1 4.4 ± 2.1 2.8 ± 1.4 11.9 ± 6.4 † ‡ NAG (mU) Basal diet 64.4 ± 15.9 82.7 ± 9.6 80.6 ± 13.2 252.0 ± 35.3 † ‡ Low-iron diet 55.2 ± 11.6 88.1 ± 35.5 66.2 ± 19.8 266.0 ± 60.1 † ‡ Transferrin (lg) Basal diet 5.4 ± 1.5 12.7 ± 1.9 6.9 ± 1.9 1378.2 ± 553.1 † ‡ Low-iron diet 4.5 ± 1.3 8.9 ± 2.9 5.4 ± 1.9 1220.5 ± 543.1 † ‡ Hb (lg)
Basal diet ND ND ND 11.1 ± 12.5 Low-iron diet ND ND ND 6.6 ± 11.4
Note. Data are presented as the mean ± SD. The numbers in parentheses are for transferrin and Hb. ND, not detected. 1976). Because ferritin synthesis was detected in the injured hepatic cells, the high plasma levels would be due to not only the increased production but also the leak of ferritin from the cells into the bloodstream. Thus, it is reasonable to describe the Cd-induced iron deficiency anemia as ''apparent iron deficiency anemia.'' To clarify how iron was involved in renal anemia induced by Cd, we made six rat groups: (A) iron-deficient diet (salineinjected rats fed both diets), (B) Cd injection (saline-and Cdinjected rats fed the basal diet), and (C) iron-deficient diet and Cd injection (saline-injected rats fed the basal diet and Cd-injected rats fed the low-iron diet) at 1 month, and the respective groups at 3 months (D, E, and F). Then, we compared the relations between plasma EPO and Hb (Supplementary fig. 6 ) or renal iron (Supplementary fig. 7 ), between the groups. At 1 month, group A showed a significant negative correlation between plasma EPO and Hb, which represents iron deficiency anemia (Spivak, 2000) . At 3 months, however, group D did not show a significant correlation. On the other hand, the relationships between plasma EPO and renal iron in both groups showed an ''L curve'': EPO production was elevated at less than around 20 lg/g of renal iron as if the switch to induce EPO was turned on when renal iron decreased below a threshold. A similar phenomenon was observed in estradiol-injected rats that showed anemia with insufficient EPO production due to renal iron accumulation (Horiguchi et al., 2005) . In addition, a multiple regression analysis for EPO in saline-injected rats demonstrated that Hb was a significant independent variable but body iron was not at 1 month, whereas this was totally reversed at 3 months (Supplementary table 5) . Actually, the L curve was more clearly observed in group D than group A. These results suggest that although Hb regulates renal EPO production at the early phase of iron deficiency, the renal iron becomes a much stronger regulator for EPO production as iron deficiency progresses.
The slope of the regression line between plasma EPO and Hb in group B was significantly flattened compared with group A (p < 0.001), indicating Cd-induced renal anemia (Spivak, . On the other hand, the regression line in group C was almost the same as that in group A (p ¼ 0.970), with the L curve between plasma EPO and renal iron. These results indicate that the Cd-induced renal anemia was totally replaced by iron deficiency anemia, in other words, the suppressive effect of Cd on EPO production was canceled by iron deficiency. Groups E and F at 3 months showed regression lines between plasma EPO and Hb almost identified to that of group B (p ¼ 0.986 and 0.949, respectively), meaning renal anemia. In addition, the L curve was not observed between plasma EPO and renal iron because of the higher range of renal iron. These results indicate that Cd suppressed renal EPO production not only directly but also indirectly through its effect to accumulate iron in the kidneys.
In addition to these ''functional'' suppression of EPO, Cd destroyed EPO-producing cells in the kidneys at 3 months quite intriguing that parenteral Cd injections enhanced duodenal iron absorption to accumulate iron in the body. Because duodenal ferroportin1, DMT1, hephaestin, and Dcytb were not significantly affected by Cd injection, the possible mechanism would be a simple increase in duodenal iron absorption according to hypertrophy of the duodenal mucosa derived from anemia. By the way, Cd suppressed hepatic hepcidin expression at 1 month, but not, even enhanced in iron deficiency, at 3 months. The contradictory effects on hepcidin would be derived from the strong IL-6 induction: Although Cd itself suppresses hepcidin induction, the Cd-induced IL-6 overcomes the suppressive effect, and even that of iron deficiency, on hepcidin induction. 
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In addition to the increase in duodenal iron absorption, hemolysis obviously contributes to the iron accumulation in organs. The deformed broken RBCs were trapped and sequestered by macrophages at the spleen, whose ferroportin1 was decreased, meaning that the iron would not be exported but accumulated in the spleen. On the other hand, intravascular hemolysis leads to the release of free Hb, which is filtered through glomeruli and absorbed in the proximal tubules (Bunn and Jandl, 1969) . The absorbed Hb is catalyzed into iron, which is stored in the tubular cells or transported to the body's iron pool as ferritin. The hepatic production of ferritin was much enhanced in Cd-injected rats, where Cd-induced IL-6 production would be implicated. Thus, an iron-holding effect of overproduced ferritin in organs would hinder the effective use of iron for erythropoiesis to lead to the apparent iron deficiency anemia.
The urinary excretion of iron was increased in the rats injected with Cd for 3 months. Because plasma transferrin is filtrated through the glomeruli and taken up at renal proximal tubules, the renal tubular dysfunction as well as the elevated plasma level would lead to the extraordinary increase in urinary transferrin in the Cd-injected rats (Norden et al., 2001) . Actually, Spearman's rank correlation coefficient between urinary transferrin and urinary NAG, and between urinary transferrin and TIBC were 0.871 and 0.653, respectively, with both p values less than 0.001. Because Hb appears in urine when the glomeruli-filtered amount surpasses the reabsorbing capacity of renal tubules (Bunn and Jandl, 1969) , the urinary Hb would be derived from not only gross hemolysis but also Cd-induced tubular dysfunction. In addition, iron itself would be lost into urine because of the decrease in reabsorption derived from DMT1's downregulation.
The mechanisms demonstrated above are illustrated in Figure 5 . The direct targets and effects of Cd are hemolysis of RBC, renal tubular injury, and liver injury. The iron released due to hemolysis accumulates in the organs but is not used effectively for erythropoiesis to compensate for the hemolytic anemia because renal EPO production is functionally and pathologically suppressed by Cd. Besides, hepatic ferritin is overproduced by Cd-induced IL-6, also contributing to iron accumulation in organs. Despite the increase in iron pools, apparent iron deficiency anemia progresses because of the ineffective erythropoiesis. Then, anemia enhances duodenal iron absorption through hypertrophy of the duodenal mucosa to induce further iron accumulation, which suppresses renal EPO production. The urinary iron loss through the excretion of transferrin and Hb as well as iron due to renal tubular dysfunction might contribute to iron deficiency. In short, insufficient EPO production and iron accumulation are the central factors driving anemia in Cd toxicity, with a vicious cycle leading to severe anemia.
In this study, we have unraveled the unique characteristics and complex mechanisms of anemia observed in chronic Cd intoxication by comprehensive investigation and consideration. This study will not only contribute to further understanding of the mechanism of Cd toxicity and taking effective therapies, such as iron or EPO treatment, for people exposed to Cd, including patients with Cd nephropathy and itai-itai disease, but also provide useful information and suggestions for other related research fields.
SUPPLEMENTARY DATA
Supplementary data are available online at http://toxsci. oxfordjournals.org/. 
ACKNOWLEDGMENT
The authors gratefully acknowledge that this publication was subsidized by JKA through its promotion funds from KEIRIN RACE. 
